Clinical Trials Directory

Trials / Completed

CompletedNCT02175420

Role of BCG as Booster Vaccination

Role of BCG Vaccination as Booster on Salmonella Typhi Vaccine

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Radboud University Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The BCG (bacillus Calmette-Guerin) vaccine is used for the protection against tuberculosis. Apart from it's protective effect against tuberculosis BCG vaccine has been shown to have non-specific effects on the innate immune system and is in epidemiological studies associated with reduced mortality due to infectious diseases. Several studies have shown that BCG can boost the effect of other vaccines. The present study aims to investigate the boosting effect of BCG on the response to typhoid fever vaccine (TFV) and to assess the non-specific effects of BCG on the innate immune system at early timepoints by vaccinating volunteers with either TFV alone or BCG followed by TFV 14 days later. The study hypothesis is that when BCG is given 14 days before typhoid fever vaccine a better vaccination result in terms of antibody production will be accomplished against typhoid fever due to the effects of BCG on the innate immune system.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBCG
BIOLOGICALTFV

Timeline

Start date
2012-07-01
Primary completion
2015-04-01
Completion
2015-11-01
First posted
2014-06-26
Last updated
2016-02-23

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02175420. Inclusion in this directory is not an endorsement.